Recently, Pennsylvania Medical Society (PAMED) submitted comments on the Municipal Police Officers’ Education and Training Commission’s (Commission) proposed regulations on Chapter 261a (relating to law enforcement mental health evaluations).

Pennsylvania’s General Election is just around the corner! On Tuesday, November 3, voters across the Commonwealth will head to the polls to elect the next governor, members of the Pennsylvania House of Representatives, and members of the Pennsylvania Senate.

In August, the Pennsylvania Department of Health (DOH) issued out proposed regulations on 28 Pa. Code Chapter 27 (Communicable and Noncommunicable Diseases).

During a recent virtual meeting, the PAMED Board of Trustees approved key governance items, prepared for House of Delegates business, and recognized an exceptional advocate for Pennsylvania physicians with the Distinguished Partner in Medicine Award.

Recently, the U.S. Department of Health and Human Services (HHS) through the Centers for Medicare & Medicaid Services (CMS) finalized changes to the Transparency in Coverage regulations to improve access to pricing information for participants, beneficiaries, and enrollees.

The Pennsylvania House of Representatives recently passed Senate Bill 115 and was amended to include provisions establishing a state-level False Claims Act. The amended legislation now awaits further consideration in the Senate.

Pennsylvania Medical Society is making the In-Office Medication Dispensing Policy available as a general resource. This policy applies only to dispensing of noncontrolled medications and is not intended to address every state and federal requirement that may apply to a particular medication.

The Statewide Special Pharmaceutical Benefits Program (SPBP) Advisory Council will hold a public teleconference meeting on Thursday, October 22, 2026, from 10 a.m. to 12 p.m.

The Preventative Health and Health Services Block Grant (PHHSBG) Advisory Committee will hold a public meeting on Monday, October 19, 2026, from 9 a.m. to 10:30 a.m. The purpose of the meeting is to discuss the status of the PHHSBG funding.

The Newborn Screening and Follow-Up Technical Advisory Board (Board) will hold a public meeting on Thursday, October 22, 2026, from 10 a.m. until 12 p.m. The meeting will be conducted both in person and as a virtual conference.

Pennsylvania has reported the first case of LACV, a mosquito-borne disease, in a patient from Crawford County which borders Ohio where LACV is endemic.

Physicians, residents, fellows and medical students from across Pennsylvania gathered at PAMED's Advocacy Day on September 29 to meet with legislators and discuss the issues shaping patient care and the practice of medicine. Together, they brought the voice of Pennsylvania physicians and future physicians to the Capitol.

On September 25, 2026, PAMED and AMA filed an amici curiae brief arguing for the Superior Court to uphold a venue selection clause that limited where a medical malpractice suit could be filed.

Once you determine that an Active-Retired license is the most appropriate license status for your circumstances, the next step is deciding when and how to transition to Active-Retired status.

The Department of Human Services (Department) is announcing its intent to allocate funds for Fiscal Year (FY) 2026-2027 inpatient disproportionate share hospital (DSH) payments.

In 1988, the Department of Human Services (Department) implemented a disproportionate share hospital (DSH) payment system.

The Sexual Assault Testing and Evidence Collection Act (Act) establishes a Statewide sexual assault evidence collection program to be administered by the Department of Health (Department).

On September 23, 2026, PAMED joined the Pennsylvania Coalition for Civil Justice Reform (PCCJR) and other aligned groups in filing an amici curiae brief in the Pennsylvania Supreme Court.

The Statewide HIV Planning Group, established by the Department of Health (Department), will hold public meetings at 625 Forster Street, Harrisburg, PA 17120

The United States Secretary of Health and Human Services added Duchenne Muscular Dystrophy (DMD) to the Recommended Uniform Screening Panel on December 16, 2025. DMD is a rare genetic disease that results in muscles becoming damaged and weaker over time. Symptoms include delayed growth, impaired speech, difficulty swallowing, loss of muscle function and progressive loss of mobility.